GENB is Generate Biomedicines, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $16.28. Market cap: $2.03B.
Stock snapshot
| Price | $16.28 |
| Market cap | $2.03B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
About GENB
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
Related non-dividend companies
Other non-dividend stocks investors research alongside GENB. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is GENB's current stock price?
GENB (Generate Biomedicines, Inc.) is currently trading at $16.28.
Does GENB pay a dividend?
GENB (Generate Biomedicines, Inc.) does not currently pay a regular dividend.
Track GENB in DiviDrip
Add GENB to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search GENB and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-02. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.